Cannara Biotech Inc (LOVE.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 05-2022 | 02-2022 | 11-2021 | 08-2021 | 05-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,053 | 956 | 775 | 796 | 771 |
| Accounts receivable | -2,797 | 249 | -513 | -206 | -1,639 |
| Other Working Capital | -3,195 | -1,559 | -1,061 | -42 | -568 |
| Other Operating Activity | 3,229 | -971 | 913 | 847 | 2,945 |
| Operating Cash Flow | $-1,710 | $-1,325 | $113 | $1,395 | $1,509 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,834 | -4,177 | -3,615 | -29,023 | -596 |
| Other Investing Activity | 17 | 18 | 5 | -9 | 10 |
| Investing Cash Flow | $-2,817 | $-4,159 | $-3,609 | $-29,032 | $-586 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | 22,000 | N/A | N/A |
| Debt Repayment | -242 | -128 | -97 | -200 | -156 |
| Other Financing Activity | 380 | -289 | -12,393 | 30,532 | -37 |
| Financing Cash Flow | $138 | $-416 | $9,509 | $30,332 | $-193 |
| Exchange Rate Effect | 9 | 15 | -29 | -100 | 103 |
| Beginning Cash Position | 8,258 | 14,143 | 8,159 | 5,564 | 4,731 |
| End Cash Position | 3,878 | 8,258 | 14,143 | 8,159 | 5,564 |
| Net Cash Flow | $-4,389 | $-5,901 | $6,013 | $2,695 | $730 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,710 | -1,325 | 113 | 1,395 | 1,509 |
| Capital Expenditure | -3,506 | -4,300 | -3,649 | -29,070 | -596 |
| Free Cash Flow | -5,215 | -5,625 | -3,535 | -27,676 | 913 |